Aruba
11/13/2026 - 11/15/2026
8:00 am - 1:00 pm
Where: Hyatt Regency Aruba
Topics include: topics: Alzheimer's disease, substance use disorders, beyond conventional therapy
Aruba
HOTEL INFO: Please call us to assist with room reservation
Hyatt Regency Aruba
Group rate $429 per night plus tax single or double occupancy. Extra adult in room $45 per night. Max of 4 people in room. Pre and post based on availability for Wednesday and Sunday nights.
www.hyatt.com/hyatt-regency/en-US/aruba-hyatt-regency-aruba-resort-spa-and-casino
Joshua Caballero, PharmD, BCPP, FCCP
University of Georgia, College of Pharmacy
Dr. Joshua Caballero completed a BA in Psychology from the University of Florida and received his PharmD from the University of Tennessee Health Science Center. Afterwards, he completed a psychiatric residency at the University of Texas Health Science Center at San Antonio and a pharmacotherapy fellowship at The Ohio State University. Dr. Caballero is board certified in psychiatric pharmacy and has worked extensively with underserved populations including establishing pharmacy outpatient clinical services. Dr. Caballero’s research interests include the effects of psychotropic agents in various populations and their impact on cognition, health literacy in HIV, and pharmacy education. He has presented many times at national conferences, secured extramural funding, and published in academic peer-reviewed journals. He has been the recipient of several teaching and advising awards at the University and national level.
Friday November 13, 2026
ALZHEIMER’S DISEASE
ACPE# TBA
Objectives:
1. Describe traditional pharmacologic and nonpharmacologic treatment options and expectations for cognitive disorders.
2. Summarize newer treatment options for cognitive disorders (e.g., Alzheimer’s disease).
3. Recognize preferred treatment options for managing comorbid psychiatric complications in patients with cognitive disorders.
4. Describe how to effectively counsel caregivers and patients (when applicable) regarding treatment options for cognitive disorders.
5. Discuss appropriate ways to provide information on support services for caregivers to individuals with cognitive disorders.
Saturday November 14, 2026
SUBSTANCE USE DISORDERS
ACPE# TBA
Objectives:
- Recognize and classify symptoms of different substance use disorders.
- Explain typical comorbidities and etiologies of substance use disorders
- Describe laws for dispensing and administrating supplies and rescue medication (i.e., needles, naloxone
- Recommend pharmacologic and non-pharmacologic treatment of substance use disorders
- Differentiate and compare various treatment options for opioid management
- Recognize the differences between cannabinoid products and their role in pain management
- Define an appropriate patient specific treatment for individuals with substance use disorders including monitoring parameters
- Counsel patients and caregivers in regards to substance use disorder treatment
- Counsel patients and caregivers regarding the use of cannabinoid products.
- Sunday November 15, 2026
-
BEYOND CONVENTIONAL THERAPY: PSYCHEDELICS, NOVEL ANTIDEPRESSANTS, EMERGING ANTIPSYCHOTICS, AND ARTIFICIAL INTELLIGENCE IN PSYCHIATRIC CARE
ACPE# TBA
Objectives:
1. Describe the role of psychedelics in mental health disorders.
2. Discuss adjunct treatment options needed to support the role of psychedelic treatment.
3. Identify advantages and disadvantages of newer agents used in the treatment of schizophrenia.
4. Evaluate the benefits and limitations of newer agents for antidepressant treatment.
5. Discuss the role of artificial intelligence in the treatment of psychiatric disorders.